Risk factor
Fair trading liquidity
Profitability factor
Weak growth
About
Realcan Pharmaceutical Group Co., Ltd. operates as a global supplier, distributing pharmaceuticals, vaccines, medical devices, and consumable medical products to healthcare institutions across the world. Beyond its core distribution activities, the company offers a suite of specialized services, including comprehensive medical logistics, third-party logistics solutions, disinfection and sterilization, and equipment leasing, alongside full-service hospital logistics support. Its operational reach spans diverse areas such as drug distribution, academic support services, medical diagnostics, financial technology applications, traditional Chinese medicine, digital health solutions, professional logistics, and integrated equipment management. The company, initially incorporated as Realcan Pharmaceutical Co., Ltd., adopted its current designation in December 2018. Realcan was established in 2004 and is headquartered in Yantai, China.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, undervalu